Oncotarget: the Medical Journal of Choice

Oncotarget is a traditional journal that does not discriminate discipline and specialty in the biomedical profession. Oncotarget is an open access journal edited by Mikhail Blagosklonny and Andrei V. Gudkov of Roswell Park Cancer Institute. The journal’s publications are made weekly. Publication of an issue or a paper is printed based on demand.


The mission of the journal is to avail scientific results to the public as soon as these are verified and authenticated. The journal also purposes to amplify the impact of clinical research by encouraging insightful review. Another of Oncotarget’s mission is to disseminate exceptional discoveries to allow others in the industry to see and contribute.

The journal aspires to eliminate the border that exists between the various specialties in science. It is the mission of the journal to bring together the various biomedical professionals. The journal equally strives to foster applications of fundamental clinical Science to combat diseases. The ideal for the journal and contributors is a life without disease, the journal looks to the medical authorities in its leadership to help researchers all over to contribute to a progressive science. Download output styles at Endnote.com.

Main Editors

Andrei Gudkov is one of the main editors of the journal: Oncotarget. His academic degrees are in experimental molecular biology. He is also an authority in oncology. He studied in Moscow State University. Andrei is the co-founder of Cleveland BioLabs as well as its

chief scientific officer. He also co-founded Tartis, Inc. He is particularly interested in drug and gene research. He also researches molecular targets.

Mikhail Blagosklonny is the other main editor of the journal Oncotarget. His area of research is cellular biology. He also researches on molecular biology. In his research, he looks at cell cycle, anticancer therapeutics, cellular senescence and signal ransduction. He is also Cancer, Am J Pathology’s associate editor. Additionally, he is the Editor- in-Chief of Cell Cycle.

The Aim and Scope- Guideline for Authors

The primary focus of the journal is cancer research publications and oncology. Owing to the dynamic nature of cancer cells, the journal also accepts articles from authors in areas such as endocrinology, age-related diseases, immunology, pathology and physiology.

Read more: https://www.dovepress.com/oncotargets-and-therapy-journal

Leave a Reply

Your email address will not be published. Required fields are marked *